Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery.
Ontology highlight
ABSTRACT: We report the synthesis of novel acid-responsive therapeutic nanoparticles (NPs) with sub-100 nm size consisting of polymer--cisplatin conjugates. The uniqueness of these drug delivery polymeric NPs lies in the covalent conjugation of each cisplatin drug to the hydrophobic segment of two biocompatible diblock copolymer chains through a hydrazone bond, resulting in highly differential drug release profile at different environmental acidity. We demonstrate that the synthesized polymer--cisplatin conjugates can readily precipitate to form sub-100 nm NPs in aqueous solution due to their very low critical micelle concentration (CMC). The resulting NPs show well-controlled cisplatin loading yield, excellent acid-responsive drug release kinetics, and enhanced in vitro cytotoxicity against ovarian
SUBMITTER: Aryal S
PROVIDER: S-EPMC2830398 | biostudies-literature | 2010 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA